CONNIE SKULSKI: Open Payments
NPI 1982144937 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 19 payments from 12 companies in 2025. Trend: 2023 $456 · 2024 $702 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $137 |
| BridgeBio Pharma, Inc. | 4 | $79 |
| SCPHARMACEUTICALS INC. | 2 | $41 |
| ABIOMED | 1 | $36 |
| PFIZER INC. | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Kestra Medical Technology Services, Inc. | 1 | $25 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Attruby, FUROSCIX, VYNDAQEL, ONPATTRO, WAINUA, OPSUMIT, INJECTAFER.
Industry payments across NY — which companies pay providers there.
